Science Bulletin·23 AugHead-to-head comparison of plasma biomarker assays across platforms for amyloid pathology in a multicenter cohortStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecA randomized, double‐blind, placebo‐controlled phase 2 study of SHR‐1707, an anti‐amyloid‐β antibody, in patients with mild cognitive impairment and mild Alzheimer's diseaseTrial in peopleInterventionsPaper